Posts tagged J.B. Chemicals & Pharmaceuticals Ltd
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| JB Chem is the preferred pick due to aggressive growth focus & high return ratios: Nirmal Bang | |
| Company: | J.B. Chemicals & Pharmaceuticals Ltd |
| Brokerage: | Nirmal Bang |
| Date of report: | September 15, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 16% |
| Summary: | JB Pharma remains our preferred pick, mainly underpinned by aggressive growth focus in the Domestic+CDMO business, high return ratios, lean B/S and healthy FCF |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Nirmal Bang |
| J.B. Chemicals & Pharmaceuticals Ltd Research Report By IndiaNivesh | |
| Company: | J.B. Chemicals & Pharmaceuticals Ltd |
| Brokerage: | IndiaNivesh |
| Date of report: | August 29, 2016 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 22% |
| Summary: | Stock on the cusp of rerating on back of US business |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
| J.B. Chemicals & Pharmaceuticals Ltd Research Report By CD Equisearch | |
| Company: | J.B. Chemicals & Pharmaceuticals Ltd |
| Brokerage: | CD Equisearch |
| Date of report: | September 14, 2016 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 33% |
| Summary: | Margin expansion is visible |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |